- Home
- CNTA vs UFPT Comparison
CNTA vs UFPT Comparison
Compare CNTA & UFPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- UFPT
- Stock Information
- Founded
- CNTA 2020
- UFPT 1963
- Country
- CNTA United Kingdom
- UFPT United States
- Employees
- CNTA 86
- UFPT N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- UFPT Medical/Dental Instruments
- Sector
- CNTA Health Care
- UFPT Health Care
- Exchange
- CNTA Nasdaq
- UFPT Nasdaq
- Market Cap
- CNTA 1.6B
- UFPT 1.8B
- IPO Year
- CNTA 2021
- UFPT 1993
- Fundamental
- Price
- CNTA $12.43
- UFPT $234.68
- Analyst Decision
- CNTA Strong Buy
- UFPT Buy
- Analyst Count
- CNTA 11
- UFPT 2
- Target Price
- CNTA $27.00
- UFPT $392.00
- AVG Volume (30 Days)
- CNTA 1.2M
- UFPT 285.1K
- Earning Date
- CNTA 08-12-2025
- UFPT 07-29-2025
- Dividend Yield
- CNTA N/A
- UFPT N/A
- EPS Growth
- CNTA N/A
- UFPT 31.41
- EPS
- CNTA N/A
- UFPT 8.15
- Revenue
- CNTA $15,000,000.00
- UFPT $547,560,000.00
- Revenue This Year
- CNTA N/A
- UFPT $22.16
- Revenue Next Year
- CNTA N/A
- UFPT $5.60
- P/E Ratio
- CNTA N/A
- UFPT $29.49
- Revenue Growth
- CNTA 118.88
- UFPT 34.43
- 52 Week Low
- CNTA $8.46
- UFPT $178.26
- 52 Week High
- CNTA $19.09
- UFPT $366.41
- Technical
- Relative Strength Index (RSI)
- CNTA 47.36
- UFPT 50.48
- Support Level
- CNTA $11.77
- UFPT $233.14
- Resistance Level
- CNTA $13.06
- UFPT $250.01
- Average True Range (ATR)
- CNTA 0.70
- UFPT 8.22
- MACD
- CNTA 0.03
- UFPT -0.90
- Stochastic Oscillator
- CNTA 51.21
- UFPT 36.23
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About UFPT UFP Technologies Inc.
UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.